Sources of Artefacts: Consequences and Solutions

  • Alison TreeEmail author
  • Maria Hawkins
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)


While PET shows much promise in improving target delineation in radiotherapy planning, there are some pitfalls which must be acknowledged before adopting wholescale implementation.


Respiratory Motion Fiducial Marker Radiotherapy Planning Dental Filling Orthopedic Device 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Antoch G, Freudenberg LS, Egelhof T, Stattaus J, Jentzen W, Debatin JF, et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med. 2002;43(10):1339–42.PubMedGoogle Scholar
  2. 2.
    Yau YY, Chan WS, Tam YM, Vernon P, Wong S, Coel M, et al. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? Journal of nuclear medicine: official publication. J Nucl Med. 2005;46(2):283–91.PubMedGoogle Scholar
  3. 3.
    Goerres GW, Hany TF, Kamel E, von Schulthess GK, Buck A. Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants. Eur J Nucl Med Mol Imaging. 2002;29(3):367–70.CrossRefPubMedGoogle Scholar
  4. 4.
    Wilson JM, Partridge M, Hawkins M. The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies. Clin Oncol (R Coll Radiol). 2014;26(9):581–96.CrossRefGoogle Scholar
  5. 5.
    Schwarzenbock S, Souvatzoglou M, Krause BJ. Choline PET and PET/CT in primary diagnosis and staging of prostate cancer. Theranostics. 2012;2(3):318–30.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Weigert M, Pietrzyk U, Muller S, Palm C, Beyer T. Whole-body PET/CT imaging: combining software- and hardware-based co-registration. Zeitschrift fur medizinische Physik. 2008;18(1):59–66.CrossRefPubMedGoogle Scholar
  7. 7.
    Goerres GW, Kamel E, Seifert B, Burger C, Buck A, Hany TF, et al. Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med. 2002;43(11):1469–75.PubMedGoogle Scholar
  8. 8.
    Nakamoto Y, Tatsumi M, Cohade C, Osman M, Marshall LT, Wahl RL. Accuracy of image fusion of normal upper abdominal organs visualized with PET/CT. Eur J Nucl Med Mol Imaging. 2003;30(4):597–602.CrossRefPubMedGoogle Scholar
  9. 9.
    Cohade C, Osman M, Marshall LN, Wahl RN. PET/CT: accuracy of PET and CT spatial registration of lung lesions. Eur J Nucl Med Mol Imaging. 2003;30(5):721–6.Google Scholar
  10. 10.
    Goerres GW, Kamel E, Heidelberg TN, Schwitter MR, Burger C, von Schulthess GK. PET/CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging. 2002;29(3):351–60.Google Scholar
  11. 11.
    Osman MM, Cohade C, Nakamoto Y, Marshall LT, Leal JP, Wahl RL. Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med. 2003;44(2):240–3.PubMedGoogle Scholar
  12. 12.
    Goerres GW, Burger C, Kamel E, Seifert B, Kaim AH, Buck A, et al. Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology. 2003;226(3):906–10.CrossRefPubMedGoogle Scholar
  13. 13.
    Erdi YE, Nehmeh SA, Pan T, Pevsner A, Rosenzweig KE, Mageras G, et al. The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. J Nucl Med. 2004;45(8):1287–92.PubMedGoogle Scholar
  14. 14.
    de Juan R, Seifert B, Berthold T, von Schulthess GK, Goerres GW. Clinical evaluation of a breathing protocol for PET/CT. Eur Radiol. 2004;14(6):1118–23.CrossRefPubMedGoogle Scholar
  15. 15.
    Nehmeh SA, Erdi YE, Meirelles GS, Squire O, Larson SM, Humm JL, et al. Deep-inspiration breath-hold PET/CT of the thorax. J Nucl Med. 2007;48(1):22–6.PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Royal Marsden NHS Foundation Trust and the Institute of Cancer ResearchLondonUK
  2. 2.CRUK MRC Oxford Institute for Radiation Oncology, Gray LaboratoriesUniversity of OxfordOxfordUK

Personalised recommendations